The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.

Shares in Bausch + Lomb were higher after the company received approval from the Food and Drug Administration for its enVista Envy full range of vision intraocular lens. Shares were recently up 23% at ...

According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...

For her, comfort is key, and she does not mind searching through multiple shops to find the perfect frame. She believes that ...

Bausch + Lomb said enVista Envy intraocular lenses will be commercially available in the U.S. on a limited basis in the coming weeks and more broadly in 2025. The company is in the process of seeking ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has ...

We recently compiled a list of the Top Investors’ Stock Portfolio: 7 Small-Cap Stocks to Invest In. In this article, we are ...

Most people over age 60 eventually get cataracts. This common condition typically starts very slowly, so those who don’t have regular eye exams may not realize what’s going on inside their eyes.

Cataracts, a common eye condition that clouds vision and hampers daily activities, can now be treated with innovative ...

ZEISS Medical Technology will showcase digital enhancements and revolutionary surgical solutions at the American Academy of ...

Good news is, Medicare does cover necessary cataract surgery including the removal of the cataract and the addition of a ...

The "Global Intraocular Lens Injector Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Product Type, End-User, Technology, Region, By Country: 2020-2030" report has been added ...